title: Methylation status of SOCS1 and SOCS3 in BCR-ABL negative and JAK2V617F negative chronic myeloproliferative neoplasms.
authors.forename: Marta
authors.initials: M
authors.lastname: Fernández-Mercado
authors.forename: Virginia
authors.initials: V
authors.lastname: Cebrián
authors.forename: Begoña
authors.initials: B
authors.lastname: Euba
authors.forename: Marta
authors.initials: M
authors.lastname: García-Granero
authors.forename: María J
authors.initials: MJ
authors.lastname: Calasanz
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Novo
authors.forename: José L
authors.initials: JL
authors.lastname: Vizmanos
authors.forename: Marina
authors.initials: M
authors.lastname: García-Delgado
mesh_terms: D018899:CpG Islands; D019175:DNA Methylation; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D019337:Hematologic Neoplasms / Q000235:genetics*; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics; D022423:Myeloid Cells / Q000473:pathology; D017354:Point Mutation; D000071222:Suppressor of Cytokine Signaling 1 Protein; D000071223:Suppressor of Cytokine Signaling 3 Protein; D050826:Suppressor of Cytokine Signaling Proteins / Q000235:genetics*
chemical_list: C108944:SOCS1 protein, human; C106644:SOCS3 protein, human; D000071222:Suppressor of Cytokine Signaling 1 Protein; D000071223:Suppressor of Cytokine Signaling 3 Protein; D050826:Suppressor of Cytokine Signaling Proteins; D016044:Fusion Proteins, bcr-abl; C507924:JAK2 protein, human; D053614:Janus Kinase 2